{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:08:31Z","timestamp":1790366911501,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":237,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1093\/annonc\/mdz164","type":"journal-article","created":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T11:07:15Z","timestamp":1558264035000},"page":"1265-1278","source":"Crossref","is-referenced-by-count":184,"title":["Molecular pathology of tumors of the central nervous system"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-0826","authenticated-orcid":false,"given":"B.W.","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.P.","family":"Priesterbach-Ackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.K.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdz164_bb0010","series-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2007"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.jnen.0000263869.84188.72","article-title":"Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p\/19q loss, and correlations with outcome","volume":"66","author":"Kros","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1093\/annonc\/mdz164_bb0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00401-010-0725-7","article-title":"Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective","volume":"120","author":"van den Bent","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1093\/annonc\/mdz164_bb0025","series-title":"World Health Organization Histological Classification of Tumours of the Central Nervous System","author":"Louis","year":"2016"},{"issue":"05","key":"10.1093\/annonc\/mdz164_bb0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5414\/NP300646","article-title":"Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers","volume":"32","author":"Berghoff","year":"2013","journal-title":"Clin Neuropathol"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0035","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00401-014-1350-7","article-title":"Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues","volume":"128","author":"Berghoff","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1093\/annonc\/mdz164_bb0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ctrv.2018.06.016","article-title":"Checkpoint inhibitors as treatment for malignant gliomas: \u201cA long way to the top\u201d","volume":"69","author":"Simonelli","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdz164_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.semcancer.2018.01.015","article-title":"Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment","volume":"52","author":"Passiglia","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"10.1093\/annonc\/mdz164_bb0050","author":"Priesterbach-Ackley","year":"2018","journal-title":"Molecular Tools for the Pathologic Diagnosis of CNS Tumors"},{"key":"10.1093\/annonc\/mdz164_bb0055","first-page":"1175","article-title":"Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p","volume":"145","author":"Reifenberger","year":"1994","journal-title":"Am J Pathol"},{"issue":"19","key":"10.1093\/annonc\/mdz164_bb0060","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","article-title":"Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas","volume":"90","author":"Cairncross","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"5897","key":"10.1093\/annonc\/mdz164_bb0065","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0070","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-008-0455-2","article-title":"Analysis of the IDH1 codon 132 mutation in brain tumors","volume":"116","author":"Balss","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1215\/15228517-2009-025","article-title":"IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas","volume":"11","author":"Ichimura","year":"2009","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0080","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2353\/ajpath.2009.080958","article-title":"IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas","volume":"174","author":"Watanabe","year":"2009","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1093\/annonc\/mdz164_bb0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1093\/annonc\/mdz164_bb0090","doi-asserted-by":"crossref","first-page":"2013.","DOI":"10.1158\/1078-0432.CCR-14-0238","article-title":"Definition of primary and secondary glioblastoma\u2013response","volume":"20","author":"Ohgaki","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0095","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00401-010-0781-z","article-title":"Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas","volume":"120","author":"Hartmann","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00401-018-1842-y","article-title":"Reconstructing the molecular life history of gliomas","volume":"135","author":"Barthel","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"7514","key":"10.1093\/annonc\/mdz164_bb0105","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature13387","article-title":"A vaccine targeting mutant IDH1 induces antitumour immunity","volume":"512","author":"Schumacher","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccell.2018.04.011","article-title":"Biological role and therapeutic potential of IDH mutations in cancer","volume":"34","author":"Waitkus","year":"2018","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1093\/annonc\/mdz164_bb0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00401-018-1808-0","article-title":"cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC)","volume":"135","author":"Louis","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-013-1141-6","article-title":"Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss","volume":"126","author":"Arita","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"15","key":"10.1093\/annonc\/mdz164_bb0125","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0130","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00401-013-1195-5","article-title":"Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system","volume":"126","author":"Koelsche","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0135","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00401-014-1326-7","article-title":"Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma","volume":"128","author":"Sahm","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"26","key":"10.1093\/annonc\/mdz164_bb0140","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Eckel-Passow","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0145","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng.3273","article-title":"Mutational landscape and clonal architecture in grade II and III gliomas","volume":"47","author":"Suzuki","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00401-014-1370-3","article-title":"ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an \u201cintegrated\u201d diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma","volume":"129","author":"Reuss","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-014-1359-y","article-title":"Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true \u201coligoastrocytoma\u201d?","volume":"129","author":"Huse","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00401-014-1353-4","article-title":"Oligoastrocytomas: throwing the baby out with the bathwater?","volume":"129","author":"Wilcox","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0165","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jnen\/nlx024","article-title":"Dual-genotype diffuse low-grade glioma: is it really time to abandon oligoastrocytoma as a distinct entity?","volume":"76","author":"Barresi","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0170","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00401-016-1608-3","article-title":"Evidence of H3 K27M mutations in posterior fossa ependymomas","volume":"132","author":"Gessi","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1093\/annonc\/mdz164_bb0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/nan.12329","article-title":"K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway","volume":"43","author":"Joyon","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/acn3.184","article-title":"Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma","volume":"2","author":"Hochart","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1093\/annonc\/mdz164_bb0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/bpa.12646","article-title":"Alternative lengthening of telomeres, ATRX loss and h3-k27m mutations in histologically defined pilocytic astrocytoma with anaplasia","volume":"29","author":"Rodriguez","year":"2019","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0190","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/bpa.12336","article-title":"Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations","volume":"26","author":"Solomon","year":"2016","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00401-014-1319-6","article-title":"Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications","volume":"128","author":"Buczkowicz","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1093\/annonc\/mdz164_bb0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1093\/annonc\/mdz164_bb0205","first-page":"185","article-title":"The anti-human trafficking collaboration model and serving victims: providers' perspectives on the impact and experience","volume":"15","author":"Kim","year":"2018","journal-title":"J Evid Inf Soc Work"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/nox149","article-title":"Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location","volume":"20","author":"Karremann","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdz164_bb0215","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/pbc.23086","article-title":"Supratentorial ependymoma in children: to observe or to treat following gross total resection?","volume":"58","author":"Venkatramani","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1093\/annonc\/mdz164_bb0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-5751-10-7","article-title":"Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts","volume":"10","author":"Ellison","year":"2011","journal-title":"J Negat Results Biomed"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0225","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","article-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","volume":"27","author":"Pajtler","year":"2015","journal-title":"Cancer Cell"},{"issue":"7489","key":"10.1093\/annonc\/mdz164_bb0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature13109","article-title":"C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma","volume":"506","author":"Parker","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1093\/annonc\/mdz164_bb0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/nan.12093","article-title":"Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma","volume":"40","author":"Broniscer","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0240","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/PAS.0b013e31827f9c5e","article-title":"Epithelioid GBMs show a high percentage of BRAF V600E mutation","volume":"37","author":"Kleinschmidt-DeMasters","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdz164_bb0245","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1593\/tlo.12328","article-title":"Analysis of the BRAF(V600E) mutation in central nervous system tumors","volume":"5","author":"Myung","year":"2012","journal-title":"Transl Oncol"},{"key":"10.1093\/annonc\/mdz164_bb0250","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.14694\/EdBook_AM.2014.34.e436","article-title":"Targeting BRAF in pediatric brain tumors","volume":"34","author":"Kieran","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0255","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00401-015-1400-9","article-title":"High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN)","volume":"129","author":"Rodriguez","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0260","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00401-012-0993-5","article-title":"CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas","volume":"123","author":"Sahm","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"11","key":"10.1093\/annonc\/mdz164_bb0265","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00701-012-1486-y","article-title":"MR imaging findings of extraventricular neurocytoma: a series of ten patients confirmed by immunohistochemistry of IDH1 gene mutation","volume":"154","author":"Yi","year":"2012","journal-title":"Acta Neurochir"},{"issue":"19","key":"10.1093\/annonc\/mdz164_bb0270","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents","volume":"343","author":"Esteller","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-015-1493-1","article-title":"Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity","volume":"131","author":"Korshunov","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0280","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00401-018-1837-8","article-title":"Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A\/B and ATRX alterations","volume":"136","author":"Reinhardt","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0285","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-017-1752-4","article-title":"Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome","volume":"134","author":"Panwalkar","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0290","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0295","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","article-title":"Molecular subgroups of medulloblastoma: the current consensus","volume":"123","author":"Taylor","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0300","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/bpa.12171","article-title":"International Society Of Neuropathology\u2013Haarlem consensus guidelines for nervous system tumor classification and grading","volume":"24","author":"Louis","year":"2014","journal-title":"Brain Pathol"},{"issue":"22","key":"10.1093\/annonc\/mdz164_bb0305","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1158\/1078-0432.CCR-14-0833","article-title":"Molecular insights into pediatric brain tumors have the potential to transform therapy","volume":"20","author":"Gajjar","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1093\/annonc\/mdz164_bb0310","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/neuonc\/now050","article-title":"Molecular subgroups of adult medulloblastoma: a long-term single-institution study","volume":"18","author":"Zhao","year":"2016","journal-title":"Neuro Oncol"},{"issue":"23","key":"10.1093\/annonc\/mdz164_bb0315","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2012.48.5052","article-title":"Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma","volume":"31","author":"Zhukova","year":"2013","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1093\/annonc\/mdz164_bb0320","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1200\/JCO.2008.17.9432","article-title":"Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci","volume":"27","author":"Pfister","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdz164_bb0325","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/nan.12443","article-title":"CNS embryonal tumours: WHO 2016 and beyond","volume":"44","author":"Pickles","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"10.1093\/annonc\/mdz164_bb0330","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1470-2045(17)30243-7","article-title":"Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study","volume":"18","author":"Schwalbe","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0335","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1470-2045(18)30242-0","article-title":"Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort","volume":"19","author":"Waszak","year":"2018","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.05.005","article-title":"Intertumoral heterogeneity within medulloblastoma subgroups","volume":"31","author":"Cavalli","year":"2017","journal-title":"Cancer Cell"},{"issue":"7663","key":"10.1093\/annonc\/mdz164_bb0345","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature22973","article-title":"The whole-genome landscape of medulloblastoma subtypes","volume":"547","author":"Northcott","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0350","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1470-2045(18)30204-3","article-title":"Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial","volume":"19","author":"Robinson","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0355","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1750-3639.2012.00610.x","article-title":"Loss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumors","volume":"23","author":"Miller","year":"2013","journal-title":"Brain Pathol"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0360","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ccell.2016.11.003","article-title":"Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors","volume":"30","author":"Torchia","year":"2016","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1093\/annonc\/mdz164_bb0365","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccell.2016.02.001","article-title":"Atypical teratoid\/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes","volume":"29","author":"Johann","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0370","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-013-1228-0","article-title":"Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity","volume":"128","author":"Korshunov","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0375","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ccr.2009.10.025","article-title":"Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors","volume":"16","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0380","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00401-008-0467-y","article-title":"Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes","volume":"117","author":"Pfister","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0385","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ng.2849","article-title":"Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR","volume":"46","author":"Kleinman","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0390","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-012-1068-3","article-title":"LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)","volume":"124","author":"Korshunov","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0395","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00401-014-1291-1","article-title":"CNS-PNETs with C19MC amplification and\/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity","volume":"128","author":"Spence","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1093\/annonc\/mdz164_bb0400","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/neuonc\/nor070","article-title":"Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma","volume":"13","author":"Miller","year":"2011","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0405","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-014-1318-7","article-title":"Germ-line and somatic DICER1 mutations in pineoblastoma","volume":"128","author":"de Kock","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0410","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","article-title":"Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations","volume":"128","author":"de Kock","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0415","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00401-018-1871-6","article-title":"Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations","volume":"136","author":"Koelsche","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0420","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","article-title":"New brain tumor entities emerge from molecular classification of CNS-PNETs","volume":"164","author":"Sturm","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0425","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11060-012-1040-z","article-title":"H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?","volume":"112","author":"Gessi","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1093\/annonc\/mdz164_bb0430","series-title":"WHO Classification of Tumours of Soft Tissue and Bone","author":"Fletcher","year":"2013"},{"key":"10.1093\/annonc\/mdz164_bb0435","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0440","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","article-title":"The 2017 World Health Organization classification of tumors of the pituitary gland: a summary","volume":"134","author":"Lopes","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0445","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bpa.12110","article-title":"High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression","volume":"24","author":"Goutagny","year":"2014","journal-title":"Brain Pathol"},{"key":"10.1093\/annonc\/mdz164_bb0450","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"6123","key":"10.1093\/annonc\/mdz164_bb0455","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1093\/annonc\/mdz164_bb0460","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","article-title":"Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations","volume":"125","author":"Reuss","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1093\/annonc\/mdz164_bb0465","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng.2552","article-title":"Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas","volume":"45","author":"Smith","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1093\/annonc\/mdz164_bb0470","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0475","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-013-1187-5","article-title":"AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry","volume":"126","author":"Sahm","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0480","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdz164_bb0485","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/neuonc\/noy178","article-title":"Molecular and translational advances in meningiomas","volume":"21","author":"Suppiah","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1093\/annonc\/mdz164_bb0490","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00401-016-1540-6","article-title":"Methylation-based classification of benign and malignant peripheral nerve sheath tumors","volume":"131","author":"Rohrich","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0495","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/PAS.0000000000000564","article-title":"Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST","volume":"40","author":"Prieto-Granada","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0500","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/modpathol.2015.134","article-title":"Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics","volume":"29","author":"Schaefer","year":"2016","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0505","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/nan.12397","article-title":"WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours","volume":"44","author":"Sahm","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0510","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00401-014-1246-6","article-title":"Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms","volume":"127","author":"Reuss","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0515","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/modpathol.2014.109","article-title":"Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas","volume":"28","author":"Pekmezci","year":"2015","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0520","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PAS.0000000000000379","article-title":"Epithelioid malignant peripheral nerve sheath tumor: clinicopathologic analysis of 63 cases","volume":"39","author":"Jo","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1093\/annonc\/mdz164_bb0525","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/PAS.0000000000000849","article-title":"SMARCB1\/INI1 loss in epithelioid schwannoma: a clinicopathologic and immunohistochemical study of 65 cases","volume":"41","author":"Jo","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdz164_bb0530","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-009-0611-3","article-title":"Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system","volume":"119","author":"Kusters-Vandevelde","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0535","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bpa.12228","article-title":"Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles","volume":"25","author":"Koelsche","year":"2015","journal-title":"Brain Pathol"},{"issue":"9","key":"10.1093\/annonc\/mdz164_bb0540","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/jid.2013.70","article-title":"Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS","volume":"133","author":"Kinsler","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1093\/annonc\/mdz164_bb0545","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bpa.12241","article-title":"Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects","volume":"25","author":"Kusters-Vandevelde","year":"2015","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0550","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11060-015-1757-6","article-title":"BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma","volume":"123","author":"Kim","year":"2015","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0555","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00401-014-1270-6","article-title":"BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma","volume":"127","author":"Larkin","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0560","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/nan.12201","article-title":"BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts","volume":"41","author":"Schweizer","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0565","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos","year":"2014","journal-title":"Nat Genet"},{"issue":"7697","key":"10.1093\/annonc\/mdz164_bb0570","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0575","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","article-title":"Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience","volume":"136","author":"Capper","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1093\/annonc\/mdz164_bb0580","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11060-019-03096-0","article-title":"Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p\/19q status in diffuse low- and high-grade gliomas","volume":"142","author":"Zhou","year":"2019","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0585","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/neuonc\/now121","article-title":"Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas","volume":"19","author":"Zhang","year":"2017","journal-title":"NEUONC"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-016-1646-x","article-title":"Announcing cIMPACT-NOW: the Consortium to inform molecular and practical approaches to CNS tumor taxonomy","volume":"133","author":"Louis","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0595","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-018-1826-y","article-title":"cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma\/anaplastic astrocytoma, IDH-mutant","volume":"135","author":"Louis","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0600","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00401-015-1398-z","article-title":"IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas","volume":"129","author":"Olar","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1093\/annonc\/mdz164_bb0605","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00401-015-1438-8","article-title":"IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO","volume":"129","author":"Reuss","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1093\/annonc\/mdz164_bb0610","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-018-1913-0","article-title":"cIMPACT-NOW update 3: recommended diagnostic criteria for \u201cDiffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV\u201d","volume":"136","author":"Brat","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0615","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-018-1849-4","article-title":"Novel, improved grading system(s) for IDH-mutant astrocytic gliomas","volume":"136","author":"Shirahata","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1093\/annonc\/mdz164_bb0620","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00401-019-01987-0","article-title":"cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF(V600E) mutation","volume":"137","author":"Ellison","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1093\/annonc\/mdz164_bb0625","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/neuonc\/noy161","article-title":"N2M2 (NOA-20) phase I\/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma","volume":"21","author":"Wick","year":"2019","journal-title":"Neuro Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419312839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419312839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/advance-article-pdf\/doi\/10.1093\/annonc\/mdz164\/28856342\/mdz164.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/30\/8\/1265\/29103518\/mdz164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T09:04:06Z","timestamp":1624698246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419312839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":124,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0923753419312839"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdz164","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}